hydrochlorothiazide has been researched along with Respiratory Distress Syndrome in 3 studies
Hydrochlorothiazide: A thiazide diuretic often considered the prototypical member of this class. It reduces the reabsorption of electrolytes from the renal tubules. This results in increased excretion of water and electrolytes, including sodium, potassium, chloride, and magnesium. It is used in the treatment of several disorders including edema, hypertension, diabetes insipidus, and hypoparathyroidism.
hydrochlorothiazide : A benzothiadiazine that is 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide substituted by a chloro group at position 6 and a sulfonamide at 7. It is diuretic used for the treatment of hypertension and congestive heart failure.
Respiratory Distress Syndrome: A syndrome characterized by progressive life-threatening RESPIRATORY INSUFFICIENCY in the absence of known LUNG DISEASES, usually following a systemic insult such as surgery or major TRAUMA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hydrochlorothiazide (HCTZ) is a commonly prescribed sulfonamide thiazide-type diuretic medication that has been associated with rare cases of noncardiogenic pulmonary edema." | 5.48 | Recurrent Hydrochlorothiazide-Induced Acute Respiratory Distress Syndrome Treated With Extracorporeal Membrane Oxygenation. ( Jansson, PS; Lee, J; Leisten, DC; Sarkisian, TM; Wilcox, SR, 2018) |
| "Hydrochlorothiazide has been shown to cause rare, but serious non-cardiogenic pulmonary edema." | 1.48 | Life-threatening idiopathic reaction to hydrochlorothiazide treated with veno-venous extracorporeal membrane oxygenation. ( Cohen, E; Kane, SP, 2018) |
| "Hydrochlorothiazide (HCTZ) is a commonly prescribed sulfonamide thiazide-type diuretic medication that has been associated with rare cases of noncardiogenic pulmonary edema." | 1.48 | Recurrent Hydrochlorothiazide-Induced Acute Respiratory Distress Syndrome Treated With Extracorporeal Membrane Oxygenation. ( Jansson, PS; Lee, J; Leisten, DC; Sarkisian, TM; Wilcox, SR, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kane, SP | 1 |
| Cohen, E | 1 |
| Jansson, PS | 1 |
| Leisten, DC | 1 |
| Sarkisian, TM | 1 |
| Wilcox, SR | 1 |
| Lee, J | 1 |
| González, G | 1 |
| Ligueros, M | 1 |
| Castro, P | 1 |
| Saavedra, H | 1 |
| Cabello, H | 1 |
| Paredes, R | 1 |
1 review available for hydrochlorothiazide and Respiratory Distress Syndrome
| Article | Year |
|---|---|
[Adult respiratory distress syndrome associated with hydrochlorothiazide: a report of 2 cases and review of the literature].
Topics: Adult; Blood Gas Analysis; Female; Humans; Hydrochlorothiazide; Middle Aged; Myocardium; Respiratory | 1988 |
2 other studies available for hydrochlorothiazide and Respiratory Distress Syndrome
| Article | Year |
|---|---|
Life-threatening idiopathic reaction to hydrochlorothiazide treated with veno-venous extracorporeal membrane oxygenation.
Topics: Aged; Diuretics; Extracorporeal Membrane Oxygenation; Female; Humans; Hydrochlorothiazide; Respirato | 2018 |
Recurrent Hydrochlorothiazide-Induced Acute Respiratory Distress Syndrome Treated With Extracorporeal Membrane Oxygenation.
Topics: Antihypertensive Agents; Extracorporeal Membrane Oxygenation; Humans; Hydrochlorothiazide; Male; Mid | 2018 |